StonvexLoading…
StonvexStonvexStonvexCore line items from LIFE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q1 2025 2025-03-31 | Annual 2024 2024-12-31 |
|---|---|---|---|---|
Revenue | $193.10M | $387.61M | $94.89M | $254.93M |
Operating Income | $-163.31M | $72.92M | $12.54M | $48.75M |
Net Income | $-166.39M | $71.15M | $12.25M | $48.83M |
EPS (Diluted) | $-3.57 | $1.22 | $0.21 | $0.85 |
Total Assets | $619.36M | $515.34M | Not available | $395.88M |
Total Liabilities | $178.04M | $135.46M | Not available | $99.03M |
Cash & Equivalents | $107.91M | $91.09M | $51.25M | $35.08M |
Free Cash Flow OCF − CapEx | $30.86M | $34.73M | $10.53M | $-11.68M |
Shares Outstanding | 0 | 16.65M | 58.76M | 16.03M |